Syneos Health
 | |
| Тип компании | Общественность (1996-2023) Частный (с 2023 года) |
|---|---|
| NASDAQ : Synh | |
| Промышленность | |
| Предшественники | Изобретательное здоровье Inc Research |
| Штаб -квартира | , Вошник |
Ключевые люди | Колин Шеннон (генеральный директор) |
| Услуги | |
| Доход |  US$5.39 billion (2021) 5,21 млрд долларов США (2021) |
| US$266 million (2022) | |
Number of employees | 28,000 (2022) |
| Website | www |
| Footnotes / references [1] | |
Syneos Health (ранее Inventiv Health Incorporated и Inc Research ) - американская компания, которая предоставляет контрактные исследования и коммерческие услуги для фармацевтических и биотехнологических компаний. Базирующаяся в Моррисвилле, штат Северная Каролина , компания специализируется на оказании помощи другим компаниям с клиническими испытаниями на поздних стадиях, но также предоставляет коммерческие услуги для рынка медицинских методов лечения.
Syneos Health была сформирована из слияния исследований Health и Inc Inc, каждое из которых была сформирована из консолидации нескольких компаний в индустрии исследований контрактов. Он был перечислен на NASDAQ до 2023 года, когда компания была частной компанией Elliott Investment Management . [ 2 ]
История
[ редактировать ]Syneos Health была сформирована в результате слияния и приобретения нескольких компаний, включая Inventiv Health и Inc Research. [ 3 ]
Through InVentiv Health, part of the company's history can be traced back to Snyder Communications, a company founded by Daniel M. Snyder in the 1980s. Snyder Communications had an initial public offering and began trading in the New York Stock Exchange in 1996.[citation needed]
The company formed a healthcare services division, Snyder Healthcare, in 1997 and acquired a number of healthcare related companies that operated or were based in the UK, France, Germany, Ireland, Holland, and Hungary. As of the end of 1998, the company generated more than $320 million in sales per year and employed about 2,800 people in the United States and more than 4,500 in Europe.[4]
In September 1999, Snyder Healthcare was spun off into an independent company called Ventiv Health Inc.,[4][5] with shareholders receiving one share of Ventiv Health Inc. for every two shares of Snyder Communications.[4][6] Eran Broshy was appointed to serve as chief executive officer and the company began trading on Nasdaq.[4][7]
In 2005, the company paid $185 million to acquire InChord Communications, a healthcare marketing agency based in Westerville, Ohio.[8][9] The company subsequently changed its name to InVentiv Health.[10] In 2006, it became listed on the S&P 600[11] and also acquired for $60 million Adheris Inc. which provides programs for patient persistence and compliance with their prescribed treatment.[12]
In 2010, the company, which at the time was traded on NASDAQ as VTIV, went private with the acquisition by Thomas H. Lee Partners in a deal estimated at $1.1 billion.[13][14] In January 2018, eight months after INC Research announced plans to acquire it,[15] the firm assumed a new name, Syneos Health, and stock symbol, Nasdaq: SYNH.[16]
In February 2019, the company announced the SEC had begun an investigation of the company's accounting policies. Syneos Health's 2018 fourth-quarter and year-end reports were delayed.[17] The COVID-19 pandemic lead to increased business for the company because of the "push to develop COVID-19 vaccines and medicines in 2020 and 2021".[18]
In April 2022, Michelle Keefe, who previously worked for two decades at the pharmaceutical Pfizer, was appointed CEO of Syneos Health to succeed Alistair Macdonald who had led the company since 2017.[19][20] In March 2023, the company signed a multi-year deal to collaborate with Microsoft Research in development of a platform to leverage machine learning for the optimization of clinical trials.[21]
On May 10, 2023, an investment consortium comprising Elliott Investment Management, Patient Square Capital and Veritas Capital, agreed to take Syneos private in a deal worth $4.46 billion, or $7.1 billion including debt.[2] This was completed on September 30, 2023.[22]
Operations
[edit]Syneos Health is currently based in Morrisville, North Carolina.[18] The company's clinical services business specializes in providing contract research for clinical trials to pharmaceutical and biotechnology companies,[23][24] while the company's commercial services provide marketing and medical affairs for their products.[20][1] As of the end of 2022, the company's clinical services business contributed to 75% of its revenue and the commercial services contributed to the remaining 25%.[1]
The company generated $4.42 billion in revenue in 2020, $5.21 billion in 2021,[19] and reported $5.39 billion in 2022.[1] Syneos Health employs about 28,000 people in 110 countries.[19]
References
[edit]- ^ Jump up to: a b c d "FORM 10-K: Syneos Health, Inc". www.sec.gov. Retrieved 2023-06-26.
- ^ Jump up to: a b "Investment consortium to take Syneos private for $4.46 billion". May 10, 2023 – via www.reuters.com.
- ^ "Merged INC Research, InVentiv rebrand as Syneos | North Carolina Biotechnology Center". www.ncbiotech.org. Retrieved 2024-01-31.
- ^ Jump up to: a b c d "InVentiv Health, Inc.". International Directory of Company Histories – via Encyclopedia.com.
- ^ "Snyder stock falls sharply amid spinoff plans". CNN Money. July 30, 1999. Retrieved 2023-06-26.
- ^ Behr, Peter (1999-06-24). "Spinoff To Split Snyder In Two". Washington Post. ISSN 0190-8286. Retrieved 2023-06-26.
- ^ "Snyder Communications spins off health care unit; Daniel Snyder, sister will be co-chairmen; Eran Broshy is CEO". Baltimore Sun. 1999-06-24. Retrieved 2023-06-26.
- ^ "Ventiv Health to acquire InChord Communications". www.bizjournals.com. Retrieved 2023-06-26.
- ^ "Ventiv Health to buy drug consulting firm". The Record from Hackensack. 2005-09-08. Retrieved 2023-06-26.
- ^ "Ventiv Health changes its name". Newspapers.com. 16 March 2006. Retrieved 2023-06-26.
- ^ "Ventiv Health joins SmallCap 600". The Courier-News. March 11, 2006. Retrieved 2023-06-26.
- ^ "Ventiv Health completes deal". The Courier-News. March 2, 2006. Retrieved 2023-06-26.
- ^ "InVentiv Health to be taken private in deal with Thomas H. Lee Partners". www.bizjournals.com. Retrieved 2023-06-26.
- ^ "UPDATE 2-THL Partners to buy InVentiv for $1.1 bln". Reuters. 2010-05-06. Retrieved 2023-06-26.
- ^ "INC Research to buy inVentiv Health in $4.6b deal". www.prweek.com. Retrieved 2023-06-26.
- ^ "INC Research no more – New name, new stock symbol after merger (+ video)". WRAL TechWire. 2018-01-10. Retrieved 2023-06-26.
- ^ Shumsky, Tatyana (2019-02-28). "Syneos Health Discloses SEC Investigation, Delays Filing Annual Report". Wall Street Journal. ISSN 0099-9660. Retrieved 2023-06-26.
- ^ Jump up to: a b Carnevali, David; Sen, Anirban; Sen, Anirban (2023-02-27). "Exclusive: Syneos Health eyes sale of company as contract backlog shrinks-sources". Reuters. Retrieved 2023-06-26.
- ^ Jump up to: a b c "Syneos Health names new CEO as revenues race past $5 billion". www.bizjournals.com. Retrieved 2023-06-26.
- ^ Jump up to: а беременный «Исполнительный голос: она сейчас отвечает на фирму Morrisville Firm Syneos Health за 5 млрд долларов» . www.bizjournals.com . Получено 2023-06-26 .
- ^ Кинан, Джозеф (20 марта 2023 г.). «Syneos в PACT с AI с Microsoft для ускорения испытаний» . Жесткая биотехнология .
- ^ «Syneos Health закрывает транзакцию с частными инвестиционными фирмами» . Syneos Health . Получено 2023-12-14 .
- ^ «Эксклюзив: Syneos Health Изучение продажи: источники» . Рейтер . 2020-03-09 . Получено 2023-06-26 .
- ^ Вак, Мария Арментал и Крис. «Частный консорциум для покупки публично торгуется Syneos Health в клубной сделке за 7,1 миллиарда долларов» . WSJ . Получено 2023-06-26 .